Literature DB >> 1386643

Use of the holmium:YAG laser in urology.

D E Johnson1, D M Cromeens, R E Price.   

Abstract

The tissue effects of a holmium:YAG (Ho:YAG) laser operating at a wavelength of 2.1 mu with a maximum power of 15 watts (W) and 10 different energy-pulse settings was systematically evaluated on kidney, bladder, prostate, ureteral, and vasal tissue in the dog. In addition, various urologic surgical procedures (partial nephrectomy, transurethral laser incision of the prostate, and laser-assisted vasovasostomy) were performed in the dog, and a laparoscopic pelvic lymph node dissection was carried out in a pig. Although the Ho:YAG laser has a strong affinity for water, precise tissue ablation was achieved in both the contact and non-contact mode when used endoscopically in a fluid medium to ablate prostatic and vesical tissue. Using the usual parameters for tissue destruction (blanching without charring), the depth of thermal injury in the bladder and ureter was kept superficial. In performing partial nephrectomies, a 2-fold reduction in the zone of coagulative necrosis was demonstrated compared to the use of the continuous wave Neodymium:YAG laser (Nd:YAG). When used through the laparoscope, the Ho:YAG laser provided precise cutting and, combined with electrocautery, allowed the dissection to proceed quickly and smoothly. Hemostatic control was adequate in all surgical procedures. Although the results of these investigations are preliminary, our initial experience with the Ho:YAG laser has been favorable and warrants further investigations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386643     DOI: 10.1002/lsm.1900120402

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  30 in total

1.  Hyperplasia suppression by Ho:YAG laser intravascular irradiation in rabbit.

Authors:  Eriko Nakatani; Tsunenori Arai
Journal:  Lasers Med Sci       Date:  2006-05-04       Impact factor: 3.161

2.  Laser prostatectomy: checkup on the promises.

Authors:  J Choi; E F Ikeguchi; A E Te; S A Kaplan
Journal:  Rev Urol       Date:  1999

Review 3.  Holmium laser for stone management.

Authors:  Sean Pierre; Glenn M Preminger
Journal:  World J Urol       Date:  2007-03-06       Impact factor: 4.226

4.  New techniques for laser prostatectomy: an update.

Authors:  Doreen E Chung; Alexis E Te
Journal:  Ther Adv Urol       Date:  2009-06

Review 5.  The eye of the endourologist: what are the risks? A review of the literature.

Authors:  Steeve Doizi; Marie Audouin; Luca Villa; Maria Rodríguez-Monsalve Herrero; Vincent De Coninck; Etienne Xavier Keller; Olivier Traxer
Journal:  World J Urol       Date:  2019-02-08       Impact factor: 4.226

Review 6.  Getting out of a tight spot: an overview of ureteroenteric anastomotic strictures.

Authors:  Niyati Lobo; Sophie Dupré; Arun Sahai; Ramesh Thurairaja; Muhammad Shamim Khan
Journal:  Nat Rev Urol       Date:  2016-06-28       Impact factor: 14.432

7.  Is in vivo analysis of urinary stone composition feasible? Evaluation of an experimental setup of a Raman system coupled to commercial lithotripsy laser fibers.

Authors:  Arkadiusz Miernik; Yvan Eilers; Christoph Nuese; Carsten Bolwien; Armin Lambrecht; Albrecht Hesse; Jens J Rassweiler; Daniel Schlager; Konrad Wilhelm; Ulrich Wetterauer; Martin Schoenthaler
Journal:  World J Urol       Date:  2015-01-04       Impact factor: 4.226

Review 8.  Safety and efficacy of thulium laser resection of bladder tumors versus transurethral resection of bladder tumors: a systematic review and meta-analysis.

Authors:  Gongwei Long; Yucong Zhang; Guoliang Sun; Wei Ouyang; Zheng Liu; Heng Li
Journal:  Lasers Med Sci       Date:  2021-02-18       Impact factor: 3.161

9.  Ureteroscopic holmium: YAG laser lithotripsy for managing ureteral calculi (a report of 168 cases).

Authors:  Zili Pang; Chuanguo Xiao; Fuqing Zeng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

Review 10.  The use of lasers in benign prostatic enlargement.

Authors:  T A McNicholas; S Singh
Journal:  Curr Urol Rep       Date:  2000-08       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.